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Hepatitis C virus (HCV) entry occurs via a pH- and clathrin-dependent endocytic pathway and requires a
number of cellular factors, including CD81, the tight-junction proteins claudin 1 (CLDN1) and occludin, and
scavenger receptor class B member I (SR-BI). HCV tropism is restricted to the liver, where hepatocytes are
tightly packed. Here, we demonstrate that SR-BI and CLDN1 expression is modulated in confluent human
hepatoma cells, with both receptors being enriched at cell-cell junctions. Cellular contact increased HCV
pseudoparticle (HCVpp) and HCV particle (HCVcc) infection and accelerated the internalization of cell-bound
HCVcc, suggesting that the cell contact modulation of receptor levels may facilitate the assembly of receptor
complexes required for virus internalization. CLDN1 overexpression in subconfluent cells was unable to
recapitulate this effect, whereas increased SR-BI expression enhanced HCVpp entry and HCVcc internaliza-
tion, demonstrating a rate-limiting role for SR-BI in HCV internalization.
Hepatitis C virus (HCV) is an enveloped positive-strand
RNA virus, classified in the genus Hepacivirus of the family
Flaviviridae. Worldwide, approximately 170 million individuals
are persistently infected with HCV, and the majority are at risk
of developing chronic liver disease. Hepatocytes in the liver are
thought to be the principal reservoir of HCV replication. HCV
pseudoparticles (HCVpp) demonstrate a restricted tropism for
hepatocyte-derived cells, suggesting that virus-encoded glyco-
protein-receptor interactions play an important role in defining
HCV tissue specificity.
Recent evidence suggests that a number of host cell mole-
cules are important for HCV entry: the tetraspanin CD81;
scavenger receptor class B member I (SR-BI) (reviewed in
reference 11); members of the tight-junction protein family
claudin 1 (CLDN1), CLDN6, and CLDN9 (12, 34, 48, 52); and
occludin (OCLN) (2, 33, 40). HCV enters cells via a pH- and
clathrin-dependent endocytic pathway; however, the exact
role(s) played by each of the host cell molecules in this process
is unclear (4, 8, 21, 34, 45).
CD81 and SR-BI interact with HCV-encoded E1E2 glyco-
proteins, suggesting a role in mediating virus attachment to the
cell (reviewed in reference 44). In contrast, there is minimal
evidence to support direct interaction of CLDN1 or OCLN
with HCV particles (12). Evans and colleagues proposed that
CLDN1 acts at a late stage in the entry process and facilitates
fusion between the virus and host cell membranes (12). We
(13, 19) and others (9, 48) have reported that CLDN1 associ-
ates with CD81, suggesting a role for CLDN1-CD81 complexes
in viral entry. Cukierman et al. recently reported that CLDN1
enrichment at cell-cell contacts may generate specialized mem-
brane domains that promote HCV internalization (9). In this
study, we demonstrate that cellular contact modulates SR-BI
and CLDN1 expression levels and promotes HCV internaliza-
tion. CLDN1 overexpression in subconfluent cells was unable
to recapitulate this effect, whereas increased SR-BI expression
enhanced HCVpp entry and HCVcc internalization rates,
demonstrating a critical and rate-limiting role for SR-BI in
HCV internalization.
MATERIALS AND METHODS
Cells and reagents. 293T cells (obtained from the ATCC) and Huh-7.5 cells
(provided by C. Rice, Rockefeller University) were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) and 1% nonessential amino acids. The primary antibodies used were
anti-NS5A 9E10 (C. Rice, Rockefeller University), anti-E2 (C1; D. Burton,
Scripps Institute), anti-CD81 (M38; F. Berditchevski, University of Birmingham,
United Kingdom), anti-SR-BI (ClaI; BD Transduction Laboratories), rabbit
anti-SR-BI sera (T. Huby, INSERM, Paris), anti-CLDN1 JAY.8 (Invitrogen),
anti-OCLN (Invitrogen), and anti-zonula occludens protein 1 (ZO-1) (Invitro-
gen). Fluorescence-labeled secondary antibodies, Alexa Fluor 488 anti-mouse
and anti-rabbit 488 immunoglobulin G (IgG), were obtained from Invitrogen;
horseradish peroxidase-conjugated secondary antibodies were purchased from
GE Healthcare, United Kingdom.
Laser scanning confocal microscopy. Huh-7.5 cells were plated on collagen-
treated 13-mm-diameter borosilicate coverslips (Fisher Scientific, United King-
dom) and fixed in methanol (CLDN1 and SR-BI) or 3% paraformaldehyde
(CD81) 24 h postseeding. Primary antibodies were applied for 1 h or overnight
(SR-BI) at 4°C. After the coverslips were washed twice with phosphate-buffered
saline (PBS), anti-mouse Alexa Fluor 488 (Invitrogen, CA) secondary antibody
was applied for 1 h. Following three washes with PBS, the cells were counter-
stained with DAPI (4,6-diamidino-2-phenylindole) (Invitrogen) for visualization
of nuclei, and the coverslips were mounted on glass slides (ProLong Gold
antifade; Invitrogen). The cells were viewed by laser scanning confocal micros-
copy on a Zeiss Meta head confocal microscope with a 63 water immersion
objective.
Linear-plot profile analysis. Receptor expression was monitored and quanti-
fied using linear-plot profile analysis in ImageJ (v1.83). Briefly, a horizontal line
of 1-pixel thickness was drawn across the cell of interest, ensuring it crossed the
plasma membrane on both sides. A list of x/y (distance/brightness) values was
used to generate a linear-plot profile histogram using the microscope’s built-in
software. Five values were recorded per peak (representing the plasma mem-
brane), and 10 random values were recorded for the area between the peaks
(representing the cytoplasm). Fifteen to 20 images were acquired for each re-
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ceptor at each cell density. Brightness data were expressed as arbitrary fluores-
cence units (AFU), as previously described (19).
HCVpp generation and infection. Pseudoviruses were generated by transfect-
ing 293T cells with plasmids carrying a human immunodeficiency virus provirus
expressing luciferase or green fluorescent protein (GFP) and the HCV strain
H77 or JFH E1E2 region, the murine leukemia virus (MLV) envelope, or a
no-envelope control as previously described (21). The supernatants were har-
vested at 48 h posttransfection, clarified, and filtered through a 0.45-m mem-
brane. Virus-containing medium was added to Huh-7.5 cells plated in 48-well
plates at 7.5  103, 15  103, or 30  103 cells/cm2 and incubated for up to 8 h;
thereafter, unbound virus was removed, and the medium was replaced with
DMEM-3% FBS. At 72 h postinfection, the cells were assessed for GFP expres-
sion by flow cytometry or lysed with cell lysis buffer (Promega, Madison, WI), and
luciferase activity measurements were taken for 10 s in a luminometer (Lumat
LB 9507). Specific infectivity was calculated by subtracting the mean no-envelope
signal from HCVpp or MLVpp signals.
HCVcc generation and infection. Plasmids encoding full-length JFH-1 (pro-
vided by T. Wakita, National Institute of Infectious Diseases, Japan) and J6/JFH
(provided by C. Rice, Rockefeller University, NY) (25, 32, 47) were used to
generate RNA as previously described (32). Briefly, RNA was transcribed using
the RiboMax express T7 kit (Promega) and electroporated into Huh-7.5 cells.
The supernatants were collected at 72 and 96 h postinfection, pooled, and stored
at 80°C. High-titer viral stocks were generated by three serial passages through
Huh-7.5 cells. The cells were fixed with methanol, and infected cells were iden-
tified by staining them for NS5A with the anti-NS5A monoclonal antibody
(MAb) 9E10 and an Alexa 488-conjugated anti-mouse IgG. Infection was quan-
tified by enumerating NS5A-positive foci, and infectivity was defined as the
number of focus-forming units (FFU)/ml.
Neutralizing-antibody-dependent HCVcc internalization assay. Huh-7.5 cells
were seeded in 48-well plates at 7.5  103, 15  103, or 30  103 cells/cm2.
Twenty-four hours postseeding, the cells were incubated on ice with JFH-1 or
J6/JFH diluted in DMEM-3% FBS. After 1 h, unbound virus was removed
by washing the plates thoroughly with ice-cold PBS. and entry was initiated by
shifting the cells to 37°C. Internalization of cell-bound particles was blocked by
adding neutralizing antibodies (nAbs) at different time point(s) after entry ini-
tiation. Infection was quantified by enumerating NS5A foci at 48 h postinfec-
tion. The percent HCVcc internalization was calculated relative to the infectivity
measured when nAbs were added 2 h post-temperature shift.
Proteinase K-dependent HCVcc internalization assay. Huh-7.5 cells (2  105)
were pelleted at 1,200 rpm for 3 min and infected with JFH-1 or J6/JFH diluted
in ice-cold HEPES-buffered DMEM-3% FBS. The cells were incubated for 1 h
on ice; thereafter, unbound virus was removed by washing the cells thoroughly
with ice-cold PBS, and the cells were resuspended in ice-cold HEPES-buffered
DMEM-3% FBS. Entry was initiated by elevating the temperature to 37°C.
Internalization of cell-bound particles was blocked by incubating the cells in
ice-cold HEPES-buffered DMEM-3% FBS containing 50 g/ml proteinase K
(Sigma-Aldrich) on ice for 1 h. Posttreatment, the cells were washed twice with
ice-cold HEPES-buffered DMEM-10% FBS to inactivate proteinase activity,
counted, and reseeded at 15  103 cells/cm2 in 24-well tissue culture plates.
Infection was quantified by enumerating NS5A foci at 48 h postinfection. The
percent HCVcc internalization was calculated relative to the infectivity measured
for untreated cells at each time point.
Generation of Huh-7.5 cells overexpressing SR-BI and CLDN1. Fully se-
quenced human SR-BI and CLDN1 genes were cloned into pTRIP lentiviral
packaging plasmids as previously described (50). TRIP lentiviruses expressing
SR-BI or CLDN1 were generated by cotransfecting 293T cells with plasmids
encoding vesicular stomatitis virus G protein, human immunodeficiency virus
Gag-Pol, and the pTRIP construct (1:3:3 ratio). Huh-7.5 cells were seeded at
1.5  105 cells per well in a six-well plate and infected 24 h later with the
packaged lentivirus diluted in DMEM supplemented with 3% FBS for 12 h. The
transduced cells were propagated in DMEM-10% FBS, and receptor expression
levels were monitored by flow cytometry.
Western blotting. Huh-7.5 cells were plated in 10-cm-diameter plastic culture
dishes at 7.5  103 or 30  103 cells/cm2 and, 24 h postseeding, lysed in RIPA
buffer containing protease (Complete; Roche) and phosphatase (PhoStop;
Roche) inhibitors for 30 min on ice. Samples were cleared by centrifugation
(20,000  g; 15 min), and the protein concentration was determined using BCA
Protein Assay Reagent (Pierce) according to the manufacturer’s instructions.
Normalized protein quantities were separated by 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride
membranes for incubation with anti-CD81, anti-SR-BI, anti-CLDN1, or anti--
actin (Sigma-Aldrich). Horseradish peroxidase-conjugated secondary antibody
was detected by enhanced chemiluminescence according to the manufacturer’s
instructions (Geneflow).
RESULTS
Cellular contact modulates HCV receptor expression and
localization. To assess the expression and localization of HCV
receptors, Huh-7.5 cells were seeded at subconfluence (7.5 
103 cells/cm2; cellular contact between 20% of neighboring
cells) or confluence (30  103 cells/cm2; intact monolayer) on
glass coverslips with CD81, CLDN1, or SR-BI or imaged by
confocal microscopy (Fig. 1A). CLDN1 and SR-BI predomi-
nantly localized to cellular junctions and showed minimal
staining of single cells at the plasma membrane, whereas CD81
localization to the plasma membrane was independent of cel-
lular contact. Quantitative analysis of receptor expression by
pseudolinear profiling of individual cells confirmed that
CLDN1 and SR-BI cell contact expression was significantly
enhanced in confluent compared to subconfluent cells (Fig.
1B) (unpaired t test; P  0.001), while CD81 expression was
unaltered (Fig. 1C). No discernible increase in cytoplasmic
CLDN1 or SR-BI levels was observed, suggesting that cellular
contact specifically modulates CLDN1 and SR-BI expression
at the cell surface. Western blotting analysis of cell lysates from
subconfluent or confluent cells demonstrated increased levels
of CLDN1 and SR-BI, but not CD81, at cell confluence (Fig.
1D). Cell surface expression of the tight-junction proteins
OCLN and ZO-1 was unchanged with cell confluence (Fig.
1E). CLDN1 and SR-BI mRNA levels in subconfluent and
confluent cells were unchanged (data not shown), suggesting
that cell density-specific regulation of CLDN1 and SR-BI ex-
pression occurs in a posttranscriptional manner.
To determine the effect(s) of increased SR-BI and CLDN1
cell contact expression on HCV infection, subconfluent and
confluent Huh-7.5 cells were inoculated with JFH-1 or J6/JFH
HCVcc for up to 6 h, and infectivity was determined 48 h
postinfection (Fig. 2A). It should be noted that under all assay
conditions the multiplicity of infection was approximately 0.3;
therefore, the number of target cells did not limit infection (24,
36). JFH-1 and J6/JFH infectivity increased linearly over time,
with both viral strains showing infection rates of 5,700 FFU/
ml/h at confluence compared to 2,700 FFU/ml/h at subcon-
fluence. Consistent with increased CLDN1 and SR-BI levels,
we measured a twofold increase in the number of JFH-1- and
J6/JFH-infected foci following a 6-h inoculation period in con-
fluent compared to subconfluent cells, suggesting a relation-
ship between target cell density, i.e., the establishment of cel-
lular contact, and HCV infectivity. Like that of HCVcc,
HCVpp-JFH (genotype 2a) and HCVpp-H77 (genotype 1a)
infectivity increased with prolonged inoculation time (Fig. 2B),
suggesting that attachment and/or internalization may be rate
limiting for viral entry. To ascertain whether this was mediated
at the level of viral entry, we measured the ability of HCVpp to
infect target cells seeded at subconfluence at standard seeding
density (15  103 cells/cm2; 40% cell-cell contact) or at
confluence. A modest increase in HCVpp luciferase activity
was observed between the subconfluent and standard seed-
ing densities, with a further twofold increase when 100% cell
contact was established (Fig. 2C). The infectivity of MLVpp
also increased significantly from subconfluent to standard
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FIG. 1. Receptor expression is modulated in confluent Huh-7.5 cells. (A) Subconfluent and confluent cells were stained with antibodies specific
for CD81, CLDN1, and SR-BI. The images were taken at63 magnification with a 1.3-numerical-aperture objective. Representative linear-profile
plots are indicated by the white lines. (B) Linear-profile histograms; the arrows indicate plasma membrane staining. (C) Receptor expression at
the plasma membrane (black bars) and cytoplasm (white bars). A minimum of 15 cells were analyzed per receptor at each seeding density. The
error bars indicate standard deviations. (D) Western blot analysis of protein expression in subconfluent (SC) and confluent (C) Huh-7.5 cells. Five
micrograms of total protein was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under nonreducing (nr) or reducing (r)
conditions, transferred to membranes, and probed for CD81, CLDN1, SR-BI, or actin. (E) Huh-7.5 cells were seeded at 4  103 cells/cm2, and
HCV receptor protein(s) (CD81, CLDN1, SR-BI, or OCLN) and tight-junction protein ZO-1 expression was quantified at subconfluence (SC),
confluence (C), and confluence plus 2 days. Receptor expression at the various time points is plotted relative to the mean number of AFU for
confluent cells. A minimum of 20 cells were analyzed for each protein at each time point.
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seeding densities; however, only a modest further increase
in luciferase activity was observed when cellular contact was
established.
HCV internalization kinetics in confluent cells. To ascertain
whether cellular contact promotes HCV internalization, we
studied the kinetics of viral escape from the neutralizing effect
of the anti-E2 MAb C1. HCVcc was pre-bound to Huh-7.5
cells on ice to prevent internalization. To initiate entry, the
cells were then shifted to 37°C, and C1 MAb was added at
different time points thereafter. The number of infected foci
reached a plateau at 2 h after entry initiation, indicating that
100% of the bound virus was resistant to neutralization (Fig.
3A). JFH-1 and J6/JFH escape rates from neutralizing C1
MAb were comparable, with 23-min and 18-min half-maximal
internalization rates (t50%) at standard seeding density, respec-
tively (Fig. 3B). JFH-1 demonstrated comparable escape from
a pooled preparation of IgGs purified from HCV-infected sub-
jects and to C1 MAb, with similar t50% (17 min and 22 min,
respectively) (Fig. 3C), confirming that the observed escape
kinetics were not specific for the C1-mediated inhibition of
E2-receptor interaction(s). Similar JFH-1 t50% (12 min) were
measured using a proteolytic escape assay, which monitors the
resistance of internalized virus to proteinase K (Fig. 3D). Un-
fortunately, the amount of proteinase K required to remove
infectious HCVcc from Huh-7.5 hepatoma cells induced their
dissociation from the tissue culture surface, requiring the cells
to be replated during the experiment. To study the effect of
cellular contact on HCV internalization kinetics, we compared
JFH-1 infection of subconfluent and confluent Huh-7.5 cells
and escape from C1 (Fig. 4). At subconfluence, 50% of cell-
bound particles became resistant to C1 MAb neutralization
within 30 min after entry initiation. However, when cellular
contact was established, the half-maximal entry time of JFH-1
was reduced to 15 min, representing a significantly accelerated
internalization rate (P  0.031; paired t test).
Roles of CLDN1 and SR-BI in HCV internalization. To
assess the significance of CLDN1 and SR-BI overexpression
for HCV internalization, Huh-7.5 cells were transduced with
lentiviral vectors expressing human SR-BI or CLDN1, and
virus internalization was determined by means of the nAb
escape assay. Transduced cells demonstrated a significant in-
crease in CLDN1 and SR-BI expression at cell-cell junctions
compared to parental cells (Fig. 5). In addition, a relatively
large proportion of receptor molecules were retained intracel-
lularly in both transduced cell populations (Fig. 5A). We noted
that overexpression of both CLDN1 and SR-BI negated the
effects of cell confluence on receptor expression. There was no
detectable effect(s) of CLDN1 overexpression on SR-BI or
CD81 levels, and vice versa (data not shown). Attempts to
generate a Huh-7.5 cell line overexpressing CD81 failed, most
likely because human hepatoma cells already express relatively
high levels of CD81.
At standard seeding density, overexpression of SR-BI in-
creased Huh-7.5 susceptibility to JFH-1 HCVcc infection
threefold (Fig. 5C), consistent with previous findings (18),
whereas increased CLDN1 expression had no detectable effect.
This suggests that SR-BI, but not CLDN1, expression levels
limit the permissivity of Huh-7.5 cells to JFH-1 HCVcc. To
assess whether high levels of CLDN1 or SR-BI altered the
internalization kinetics of cell-bound virus, we measured C1
escape in transduced Huh-7.5 cells plated at standard seeding
density (Fig. 6). CLDN1 overexpression had no effect on
FIG. 2. Effect of cellular contact on HCVcc and HCVpp infection. (A) Huh-7.5 cells were plated at subconfluence (F) (7.5  103/cm2) or
confluence (E) (30  103/cm2) and 26 h postplating were infected with JFH-1 or J6/JFH HCVcc at an approximate multiplicity of infection of 0.3
for 1 to 6 h. Forty-eight hours postinfection, infectivity was quantified by counting NS5A-positive foci. The values represent means 	 standard
deviations. (B) Huh-7.5 cells at standard seeding density (15  103 cells/cm2) were infected with HCVpp-JFH or HCVpp-H77, envelope-deficient
pseudoparticles (NoEnv), and MLVpp for up to 8 h at an approximate multiplicity of infection of 0.1. Viral infectivity (percent GFP-positive cells)
was determined by flow cytometry. (C) Huh-7.5 cells were plated at different densities and infected with HCVpp-H77 or MLVpp for 5 h. Luciferase
activity (in relative light units [RLU]) was measured 72 h postinfection. Statistical analyses were performed using unpaired t tests. , P  0.01.
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JFH-1 internalization, whereas in SR-BI-overexpressing cells,
50% of cell-bound particles became resistant to neutralization
within 6 min after entry initiation compared to a t50% of 18 min
for parental cells. These data highlight the crucial role of
SR-BI for HCV entry and suggest that receptor levels define
virus internalization rates.
DISCUSSION
We demonstrated that HCV entry is dependent on the tar-
get cell density, and this is most likely explained by increased
CLDN1 and SR-BI expression in areas of cell-cell contact.
CLDN1 and SR-BI demonstrated significantly elevated cell
contact localization and expression in confluent cells (Fig. 1),
whereas mRNA levels were unaffected by the confluence sta-
tus, suggesting posttranscriptional regulation of SR-BI and
CLDN1 expression. In contrast, CD81 and OCLN demon-
strated a uniform distribution at the plasma membrane of
single cells, with no detectable enrichment at high density (Fig.
1A and E). Western blot analysis of total cell lysates confirmed
that CD81 protein levels were unaffected by the confluence
status. However, Huh-7.5 cells express relatively high levels of
CD81, and we presume that modest changes in CD81 expres-
sion may be undetectable. These findings suggest that the Huh-
7.5 cell density modulates CLDN1 and SR-BI protein expres-
sion and localization with possible consequences for HCV
entry.
Cell surface expression of membrane proteins involves the
sorting of proteins from the trans-Golgi network to the plasma
FIG. 3. Time course of HCVcc sensitivity to antibody-mediated neutralization. (A) Neutralizing activity of the anti-E2 nAb C1. Huh-7.5 cells
plated at standard seeding density (15  103 cells/cm2) were incubated with JFH-1 at an approximate multiplicity of infection of 0.3 for 1 h on ice;
thereafter, entry was initiated by elevating the temperature to 37°C. At different time points after entry initiation, virus infectivity was neutralized
using 10 g/ml C1. Infectivity (FFU) reached a plateau approximately 2 h after entry initiation. The data are from a representative experiment
performed in quadruplicate. The error bars indicate standard deviations. (B) JFH-1 and J6/JFH internalization. Huh-7.5 cells plated at standard
seeding density (15  103 cells/cm2) were infected with JFH-1 or J6/JFH for 1 h on ice, and entry was initiated as described for panel A. To
neutralize further infection, an anti-E2 antibody (C1) was added to the cells at the indicated time points. (C) Neutralization with anti-E2 antibody
and polyclonal anti-HCV human IgG. Huh-7.5 cells were infected with JFH-1 as described for panel B. Virus infectivity was neutralized using
anti-E2 antibody (C1) or a mixture of polyclonal human IgGs. Infectivity was enumerated 48 h later. The arrows show the t50%. (D) Neutralization
with proteinase K. Huh-7.5 cells were infected with JFH-1 as described for panel B, and cell surface-bound virus was inactivated by proteinase K
digestion (50 g/ml) at the indicated time points. The values are relative to the infectivity measured at 2 h after entry initiation (the values shown
are the means of three experiments, each with observations in triplicate; the error bars indicate standard deviations).
FIG. 4. Modulation of HCVcc entry kinetics with cell confluence.
Huh-7.5 cells were plated at subconfluence (F) (7.5 103 cells/cm2) or
confluence (E) (30  103 cells/cm2) and incubated with JFH-1 at an
approximate multiplicity of infection of 0.3 for 1 h on ice. After entry
initiation, internalization was blocked with anti-E2 antibody (C1) at
the indicated time points. Infectivity was determined 48 h postinfec-
tion. The values are relative to the infectivity measured at 2 h after
entry initiation (the values shown are the means of three experiments,
each with observations in triplicate; the error bars indicate standard
deviations). Statistical analysis was performed using a two-tailed
paired t test to compare percent entry at individual time points.
VOL. 83, 2009 CELL DENSITY, RECEPTOR EXPRESSION, AND HCV INFECTION 12411
membrane domain and anchoring and/or retention at the cell
surface, followed by endocytosis, transcytosis, or recycling (re-
viewed in reference 5). Protein trafficking to the cell surface is
largely mediated by peripheral membrane (PDZ domain) pro-
teins, which interact with the C-terminal PDZ ligand binding
domains of membrane proteins, including CLDN1 and SR-BI
(23, 42). The mechanisms regulating membrane trafficking are
incompletely understood; however, it has been demonstrated
that adaptor proteins, such as PDZK1 and ZO-1 and -2, local-
ize to sites of cell-cell contact and interact directly with
CLDN1 and OCLN (14, 23, 26, 37).
There have been reports of CLDN1 cell contact localization
in human, murine, and canine tumor and nontumor cell lines
(16, 17, 20, 22, 29). Indeed, human breast cancer cells display
cell density-specific modulation of CLDN1 expression inde-
pendently of mRNA levels. Hepatic SR-BI expression is post-
translationally regulated by the adaptor protein PDZK1 (27);
furthermore, by stabilizing SR-BI plasma membrane expres-
sion, PDZK1 determines SR-BI localization and function
within the liver (42, 43).
SR-BI and CD81 surface expression levels have been re-
ported to limit HCV infection (18, 28). Consistent with these
findings, HCVpp demonstrated a significant increase in lucif-
erase activity at cell confluence, when cell-cell contact was
established between cells in the culture (Fig. 2C). The same
effect was observed for HCVcc infection, with JFH-1 and J6/
JFH infection increasing significantly when cellular contact was
established (Fig. 2). To assess whether cellular contact pro-
moted the internalization of cell-bound HCVcc, we examined
the ability of an anti-E2 antibody to inhibit infection of sub-
confluent and confluent cells when added at various times
during the entry process. Previous reports have demonstrated
that HCVpp and HCVcc escape the inhibitory activity of an-
tibodies targeting HCV E2, CD81, and SR-BI approximately
17 to 20 min after entry initiation, consistent with the internal-
ization rates reported in this study (3, 12, 49). Interestingly,
Meertens and colleagues reported that half-maximal HCVpp
fusion requires 73 min, as determined by sensitivity to bafilo-
mycin A (34), suggesting a significant delay in virus internal-
ization and subsequent fusion with early endosome mem-
branes. We note that the inhibitory activity of C1 was reduced
earlier at cell confluence than at subconfluence, with half-
maximal inhibition being attained at 15 min and 30 min, re-
spectively (Fig. 4). Moreover, we observed that HCVcc inter-
nalization in subconfluent and confluent cells differed
significantly during the first 30 min of the entry process and
FIG. 5. CLDN1 and SR-BI overexpression in Huh-7.5 cells.
(A) Parental and pTRIP-transduced cells were plated at standard
seeding density (15  103 cells/cm2) and, 26 h post-plating, were
stained with antibodies specific for CLDN1 or SR-BI. (B) Receptor
expression levels at the plasma membrane (black bars) and cytoplasm
(white bars) were determined by linear-profile plot analysis. Statistical
analysis was performed using an unpaired t test. The error bars indi-
cate standard deviations. (C) Parental and transduced cells at standard
seeding density were infected with JFH-1 at an approximate multiplic-
ity of infection of 0.3 for 1 h. JFH-1 infectivity (FFU/ml) was deter-
mined by enumerating NS5A foci at 48 h postinfection. Asterisks
indicate statistical significance (, P  0.01; , P  0.001).
FIG. 6. Effect of CLDN1 and SR-BI overexpression on JFH-1 en-
try kinetics. Huh-7.5 cells transduced to overexpress CLDN1 (A) or
SR-BI (B) were plated at standard seeding density and incubated with
JFH-1 at an approximate multiplicity of infection of 0.3 for 1 h on ice.
Entry was initiated by elevating the temperature to 37°C; thereafter,
infection was further neutralized with anti-E2 antibody (C1). NS5A
foci were enumerated 48 h postinfection, and the percentage of C1-
resistant particles was calculated relative to the infectivity measured at
the 2-h time point. The values shown are the means of three experi-
ments, each with observations in triplicate; the error bars indicate
standard deviations.
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converged thereafter, suggesting that cellular contact modu-
lates an early step in HCV internalization.
To further dissect the role(s) of CLDN1 and SR-BI in cell
contact-mediated modulation of HCV entry, we studied
HCVcc internalization in subconfluent Huh-7.5 cells trans-
duced to overexpress CLDN1 or SR-BI. Cells transduced to
overexpress CLDN1 were no more susceptible to JFH-1
HCVcc than parental cells (Fig. 5); furthermore, CLDN1 over-
expression had no detectable effect on virus internalization
(Fig. 6), despite a significant increase in cell contact expression
levels. Taken together, these data suggest that CLDN1 expres-
sion levels do not limit the frequency or rate of HCVcc inter-
nalization into Huh-7.5 cells. CLDN1 is proposed to act at a
late postbinding stage of viral entry (12). Several reports have
demonstrated that mutation or deletion of a domain(s) re-
quired for CLDN1 internalization has minimal effect on HCV
entry (9, 12, 19), suggesting that CLDN1 internalization per se
is not essential for HCV particle entry. Our recent data suggest
that CLDN1 may interact with CD81 and modulate HCV
E1E2 interaction(s) and lateral particle trafficking to mem-
brane domains amenable to internalization (H. Harris and M.
Farquhar, unpublished data).
SR-BI overexpression enhanced HCV internalization (Fig.
5C), consistent with a model in which elevated SR-BI expres-
sion levels enhance HCV internalization in confluent cells.
Silencing SR-BI expression reduced the infectivity of HCVcc
(49) and HCVpp bearing E1E2 glycoproteins from different
genotypes (30), while the neutralizing activity of patient sera
increased as a result of low SR-BI levels (46). Concomitantly,
we observed that SR-BI overexpression promoted HCVpp en-
try and “attenuated” the neutralizing activity of MAbs and
polyclonal antibodies (reference 18 and data not shown).
These observations suggest that SR-BI expression levels not
only modulate Huh-7.5 permissivity per se (Fig. 5) (18), but are
rate limiting for HCVcc particle internalization (Fig. 6). Com-
pared to other enveloped viruses, HCVcc internalization is
slow, which may reflect the time required to form higher-order
protein complexes between CD81, SR-BI, CLDN1, and OCLN
(10, 19, 34). High SR-BI surface expression may facilitate the
assembly of these complexes, promoting the internalization of
cell-bound particles. Of note, the anti-E2 MAb (C1) used to
neutralize surface-bound virus particles (Fig. 3, 4, and 6) is
reported to act by inhibiting E2-CD81 interactions (31) and yet
retains its neutralizing capacity after particle attachment (Fig.
3A). This is consistent with other observations that CD81 acts
at a stage following the primary interaction of HCV particles
and target cells (12, 15, 35).
Persistence is a hallmark of HCV infection and is attribut-
able to the ability of the virus to evade host cellular and
humoral immune responses. The mechanism of action of
HCV-specific nABs is incompletely understood; however,
there have been several reports that antibodies inhibit HCV
attachment to the cell surface by targeting the CD81 binding
site and hypervariable region of glycoprotein E2 (1, 38, 39, 51).
During viral entry, both regions need to be accessible to their
cellular binding partners (6, 7) and may become transiently
exposed to nAbs; consequently, the rate at which a virus par-
ticle internalizes may define its sensitivity to nAbs. Hepato-
cytes, which are the main reservoir of HCV replication, are
tightly packed; furthermore, we have previously demonstrated
high levels of SR-BI in healthy human liver (41). It is interest-
ing to speculate that the internalization rates and nAb escape
we have observed in confluent Huh-7.5 cells, with high SR-BI
and CLDN1 expression, may better represent hepatocytes in
the liver. If this is indeed the case, the rate of internalization of
virus particles in vivo may be rapid, offering further explana-
tion for the ability of HCV to prevail in the face of a humoral
immune response.
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